FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091128 [Registered on: 18/07/2025] Trial Registered Prospectively
Last Modified On: 11/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical trial to study the effects of two drugs, ketamine and midazolam as pre medicant in pediatric patient undergoing elective surgery 
Scientific Title of Study   A study comparing nebulised ketamine and midazolam as pre medicant in pediatric patient undergoing elective surgery 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanjay Johar 
Designation  Professor 
Affiliation  Pt BD Sharma PGIMS Rohtak 
Address  Department of Anesthesiology and critical care Pt BD Sharma PGIMS Rohtak

Rohtak
HARYANA
124001
India 
Phone  9416050652  
Fax    
Email  sanjays321@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mansi Sukhija 
Designation  junior resident  
Affiliation  Pt BD Sharma PGIMS Rohtak 
Address  Department of Anesthesiology and critical care Pt BD Sharma PGIMS Rohtak Haryana 124001 India

Rohtak
HARYANA
124001
India 
Phone  9728776410  
Fax    
Email  mansisukhija261097@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mansi Sukhija  
Designation  Junior resident  
Affiliation  Pt BD Sharma PGIMS Rohtak 
Address  Department of Anesthesiology and critical care Pt BD Sharma PGIMS Rohtak Haryana 124001 India

Rohtak
HARYANA
124001
India 
Phone  9728776410  
Fax    
Email  mansisukhija261097@gmail.com  
 
Source of Monetary or Material Support  
Institutional, Pt BD Sharma Rohtak Haryana 124001 India 
 
Primary Sponsor  
Name  Pt BD Sharma PGIMS Rohtak 
Address  Department of Anesthesiology and critical care PGIMS Rohtak Haryana 124001 INDIA 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanjay Johar  Pt BD Sharma PGIMS Rohtak  Department of anesthesiology and critical care Pt BD Sharma PGIMS Rohtak Haryana 124001 India
Rohtak
HARYANA 
9416050652

sanjays321@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Biomedical research ethics committee, Pt BD Sharma PGIMS/UHS Rohtak  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  ketamine   ketamine(2mg/kg) diluted to final volume of 3mL of solution using 0.9% normal saline, nebulized to pediatric patients for 15 minutes before transfer to operating room and assesing for Ramsay sedation score, separation score, face mask acceptance score and vitals at interval of 5 mins for 30 mins 
Comparator Agent  midazolam  Midazolam(0.2mg/kg) diluted to final volume of 3ml of solution using 0.9% normal saline, nebulized to pediatric patients for 15 mins before tranfer to operating room and assessing for Ramsay sedation score, separation score, facemask acceptance score and vitals at interval of 5mins for 30mins  
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  ASA grade I & II scheduled to undergo various elective surgical procedures 
 
ExclusionCriteria 
Details  1. children with history of developmental delay
2. children with systemic illness like - cardiac
diseases, neurological, liver and renal disease.
3.parents refusing to give consent.
4. known allergy or hypersensitivity to ketamine or midazolam 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Comparison of level of sedation and effectiveness of nebulised ketamine and midazolam as premedicant   From the time of administration of drug at every 5 mins interval for first 30 mins  
 
Secondary Outcome  
Outcome  TimePoints 
To compare time of onset of action, ease of child-parent separation, ease of induction in operative room, and effect of two drugs on intra-operative hemodynamics   From the time of administration of drug at every 5 mins interval for first 30 mins 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   30/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The present prospective study will be conducted in the department of anesthesia and critical care, PGIMS Rohtak. Written informed consent will be taken from patients included. Then comparison of effectiveness of nebulised ketamine and midazolam as pre medicants. Data will be compiled and analysed with appropriate statistical test. 
Close